Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2009-12-15 / Clin. Cancer Res. 2009 Dec;15(24):7726-7736Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2009-08-08 / Med. Oncol. 2010 Sep;27(3):736-42Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer
/in Colorectal Cancer, International Publications /von 2009-07-08 / Cochrane Database Syst Rev 2009 Jul;(3):CD006269Coordination of intratumoral immune reaction and human colorectal cancer recurrence
/in Colorectal Cancer, International Publications /von 2009-03-03 / Cancer Res. 2009 Mar;69(6):2685-93Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice
/in Colorectal Cancer, International Publications /von 2009-02-15 / Int. J. Cancer 2009 Feb;124(4):877-88Recent advances in cancer immunotherapy with an emphasis on vaccines
/in Colorectal Cancer, International Publications /von 2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-8The essential role of the in situ immune reaction in human colorectal cancer
/in Colorectal Cancer, International Publications /von 2008-06-17 / J. Leukoc. Biol. 2008 Oct;84(4):981-7Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
/in Colorectal Cancer, International Publications, IOZK Veröffentlichungen /von 2008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-7Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
/in Colorectal Cancer, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution